Source: Eur Respir J 2015; 45: 1642-1652
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Lee Nelson, Leo Yee-Sin, Cao Bin, Chan Paul K.S., Kyaw W.M., Uyeki Timothy M., Tam Wilson W.S., Cheung Catherine S.K., Yung Irene M.H., Li Hui, Gu Li, Liu Yingmei, Liu Zhenjia, Qu Jiuxin, Hui David S.C.. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J 2015; 45: 1642-1652

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of the neuraminidase inhibitors in treating influenza pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004 Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001 Combination of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with influenza Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020 Inhaled corticosteroids and influenza A (H1N1) viral pneumonia Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020 Year: 2021 Long-term outcomes after viral pneumonia caused by influenza A (H1N1) Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 The humoral immune response to influenza vaccination in lung transplant patients Source: Eur Respir J 2001; 18: 971-976 Year: 2001 Differences between asthmatics and nonasthmatics hospitalised with influenza A infection Source: Eur Respir J 2013; 41: 824-831 Year: 2013 Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection? Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir Source: Eur Respir J 2014; 44: 535-537 Year: 2014 Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model Source: Eur Respir J 2011; 38: 401-408 Year: 2011 Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020 Seasonal influenza vaccination rates in chronic asthma patients Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients Source: Annual Congress 2011 - Lung transplantation Year: 2011 Early use of oseltamivir protected from respiratory failure in patients with acute flu syndrome during 2009 Brazilian influenza H1N1 pandemics Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Effects of statin therapy on the risk of serious outcomes during influenza epidemics Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012